Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding
Open Access
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 59 (7) , 1266-1275
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Apolipoprotein C-IIICirculation Research, 2013
- Apolipoprotein E in VLDL and LDL With Apolipoprotein C‐III is Associated With a Lower Risk of Coronary Heart DiseaseJournal of the American Heart Association, 2013
- Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart DiseaseCirculation, 2011
- Exome Sequencing,ANGPTL3Mutations, and Familial Combined HypolipidemiaNew England Journal of Medicine, 2010
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studiesThe Lancet, 2010
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent CardioprotectionScience, 2008
- Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein BJournal of Clinical Lipidology, 2007
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987